NEURONES - Company Capsule by ICDResearch

VIEWS: 2 PAGES: 27

More Info
									NEURONES

_________________________________________________________________________________



NEURONES                                                                Financial Snapshot

                                                                        Operating Performance
Fast Facts
                                Building 'Le Clemenceau 1', Nanterre,   The company reported revenue of US$319.42 million
Headquarters Address
                                92024,France                            during the fiscal year 2010 (2010). The company's
                                                                        revenue grew at a CAGR of 18.41% during 2006–
Telephone                       + 33 1 41374137
                                                                        2010, with an annual growth of 6.28% over 2009. In
                                                                        2010, the company recorded an operating margin of
Fax                             + 33 1 47244046                         10.25%, as against 8.81% in 2009.

Website                         www.neurones.net
                                                                        Revenue and Margins
Ticker Symbol, Stock Exchange   NRO, Euronext Paris

Number of Employees             3,000

Fiscal Year End                 December

Revenue (in US$ million)        319.42

Revenue (in EUR million)        239.57




                                                                        Return on Equity

                                                                        The company recorded a return on equity (ROE) of
                                                                        11.55% for 2010, as compared to its peers, Sopra
                                                                        Group (Ticker: SOP), Assystem Group (Ticker: ASY)
                                                                        and GFI Informatique (Ticker: GFI), which recorded
                                                                        ROEs of 20.51%, 15.13% and 6.77% respectively.
                                                                        The company reported an operating margin of
                                                                        10.25% in 2010.


                                                                        Return on Equity




                                                                        Liquidity Position

                                                                        The company reported a current ratio of 2.13 in 2010,
                                                                        as compared to its peers, Sopra Group, Assystem
                                                                        Group and GFI Informatique, which recorded current
                                                                        ratios of 1.08, 1.42 and 0.93 respectively. As of
                                                                        December 2010, the company recorded cash and
                                                                        short-term investments of worth US$91.48 million,
                                                                        against US$0.16 million current debt. The company
                                                                        reported a debt to equity ratio of 0.00 in 2010 as
                                                                        compared to its peers, Sopra Group, Assystem Group
                                                                        and GFI Informatique, which recorded debt to equity
                                                                        ratios of 0.24, 0.63 and 0.66 respectively.




___________________________________________________________________________________________

NEURONES - Company Profile                                                                                     Page 1
NEURONES

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 5
    1.1       Company Overview ................................................................................................................................................5
    1.2       Major Products and Services .................................................................................................................................6
2     Analysis of Key Performance Indicators ............................................................................................... 7
    2.1       Five Year Snapshot: Overview of Financial and Operational Performance Indicators ..........................................7
    2.2       Key Financial Performance Indicators .................................................................................................................10
      2.2.1       Revenue and Operating Profit .........................................................................................................................10
      2.2.2       Asset, Liabilities and Capex .............................................................................................................................11
      2.2.3       Operational Efficiency ......................................................................................................................................12
      2.2.4       Solvency ..........................................................................................................................................................13
      2.2.5       Valuation ..........................................................................................................................................................14
    2.3       Competitive Benchmarking ..................................................................................................................................15
      2.3.1       Market Capitalization .......................................................................................................................................16
      2.3.2       Efficiency ........
								
To top